The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Insulin therapy increases airway responsiveness in type 2 diabetes patients Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005
Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
The effect of inhaled corticosteroids on airway mast cells in type 2 low asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2 Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016
Airway hyperresponsiveness to mannitol is an independent marker of asthma control and disease phenotype Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
Cell type specific heat-shock-protein responses to bronchial thermoplasty in severe asthma treatment Source: International Congress 2018 – New modalities in asthma treatment Year: 2018
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Sustained asthma control can eliminate airway hyperreactivity: a 3 year study Source: Eur Respir J 2006; 28: Suppl. 50, 218s Year: 2006
Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
F eNO -based asthma management results in faster improvement of airway hyperresponsivenessSource: ERJ Open Res, 4 (4) 00147-2017; 10.1183/23120541.00147-2017 Year: 2018
Comparative airway response to high- versus low-molecular weight agents in occupational asthma Source: Eur Respir J 2009; 33: 734-739 Year: 2009
How much do varying definitions of atopy and airway hyperresponsivenss affect asthma phenotype Source: Eur Respir J 2001; 18: Suppl. 33, 287s Year: 2001
Absence of association between bronchial hyperresponsiveness and current wheezing in school children in Brazil: a different phenotype of asthma? Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006
The airway microbiota is significantly altered in asthma patients with airway hyperresponsiveness to mannitol Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015
Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
Self-reported lack of adherence is associated with increased airway hyperresponsivness in asthma Source: International Congress 2015 – Best abstracts in chronic care Year: 2015